• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞生长因子及其受体(Met)在人乳腺癌中的共表达。

Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.

作者信息

Tuck A B, Park M, Sterns E E, Boag A, Elliott B E

机构信息

Department of Pathology, Kingston General Hospital, Ontario, Canada.

出版信息

Am J Pathol. 1996 Jan;148(1):225-32.

PMID:8546209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1861613/
Abstract

Expression of hepatocyte growth factor (HGF) and HGF receptor (HGFR, product of the met proto-oncogene) mRNA were examined by nonisotopic in situ hybridization in a spectrum of benign and malignant human breast tissues. mRNA for both HGFR and HGF was detected in benign ductal epithelium. Epithelial expression of HGF mRNA was particularly intense in regions of ductal epithelial hyperplasia. Positive expression of HGF (but not HGFR) mRNA was also found in adipocytes, endothelial cells, and to varying degrees in stromal fibroblasts. In 12 of 12 cases of ductal carcinoma in situ and infiltrating ductal carcinoma, carcinoma cells showed a heterogeneous pattern of expression for both HGFR and HGF mRNA. In infiltrating ductal carcinomas, intense expression of HGFR mRNA was not restricted to ductular structures but as also seen in non-duct-forming carcinoma cells. The same zones of the tumors (most commonly at the advancing margins) that expressed strongly HGFR mRNA often were also strongly positive for HGF mRNA, suggesting a possible autocrine effect. The expression pattern of HGFR protein in 25 cases including the same series of tissues used for in situ hybridization analysis was similar to that of HGFR mRNA, as determined by an immunoperoxidase technique. The finding that HGFR is expressed by both benign and malignant epithelium, and its not restricted to duct-forming structures, suggests that, although the potential for HGF/HGFR binding is maintained in malignancy, the response to ligand binding at the level of the receptor or the cellular response to receptor activation may change at some point during progression.

摘要

采用非同位素原位杂交技术,检测了一系列人乳腺良恶性组织中肝细胞生长因子(HGF)及其受体(HGFR,原癌基因met的产物)mRNA的表达情况。在良性导管上皮中检测到了HGFR和HGF的mRNA。HGF mRNA的上皮表达在导管上皮增生区域尤为强烈。在脂肪细胞、内皮细胞以及不同程度的基质成纤维细胞中也发现了HGF(而非HGFR)mRNA的阳性表达。在12例原位导管癌和浸润性导管癌中,癌细胞均呈现出HGFR和HGF mRNA的异质性表达模式。在浸润性导管癌中,HGFR mRNA的强烈表达不仅局限于导管结构,在非导管形成的癌细胞中也可见。肿瘤中表达强烈HGFR mRNA的相同区域(最常见于进展边缘)通常HGF mRNA也呈强阳性,提示可能存在自分泌效应。通过免疫过氧化物酶技术检测,包括用于原位杂交分析的相同系列组织在内的25例组织中HGFR蛋白的表达模式与HGFR mRNA相似。HGFR在良性和恶性上皮中均有表达且不限于导管形成结构,这一发现表明,尽管在恶性肿瘤中仍存在HGF/HGFR结合的潜力,但在肿瘤进展过程中的某个阶段,受体水平对配体结合的反应或细胞对受体激活的反应可能会发生变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ccf/1861613/0b92a207c838/amjpathol00037-0226-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ccf/1861613/dc83943bc83c/amjpathol00037-0224-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ccf/1861613/95e9ade614a5/amjpathol00037-0225-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ccf/1861613/0b92a207c838/amjpathol00037-0226-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ccf/1861613/dc83943bc83c/amjpathol00037-0224-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ccf/1861613/95e9ade614a5/amjpathol00037-0225-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ccf/1861613/0b92a207c838/amjpathol00037-0226-a.jpg

相似文献

1
Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.肝细胞生长因子及其受体(Met)在人乳腺癌中的共表达。
Am J Pathol. 1996 Jan;148(1):225-32.
2
Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.乳腺原位癌、浸润性癌和转移性癌中的血管基质形成。
Clin Cancer Res. 1999 May;5(5):1041-56.
3
Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea.泪腺、泪液及角膜中的肝细胞生长因子和肝细胞生长因子受体。
Invest Ophthalmol Vis Sci. 1996 Apr;37(5):727-39.
4
Expression of the hepatocyte growth factor/scatter factor receptor tyrosine kinase is localized to epithelia in the adult mouse.肝细胞生长因子/分散因子受体酪氨酸激酶的表达定位于成年小鼠的上皮组织。
Lab Invest. 1995 Oct;73(4):483-91.
5
Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.在小鼠乳腺癌中鉴定肝细胞生长因子自分泌环。
Cell Growth Differ. 1996 Feb;7(2):263-70.
6
Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.小鼠I型小胆管反应期间胆管上皮细胞中的白细胞介素-6、肝细胞生长因子及其受体:导管周围炎性细胞和基质细胞与胆管上皮之间的相互作用
Hepatology. 1998 Nov;28(5):1260-8. doi: 10.1002/hep.510280514.
7
Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer.
Cancer Res. 1994 Nov 15;54(22):5775-8.
8
Hepatocyte growth factor/scatter factor expression in human mammary epithelium.人乳腺上皮细胞中肝细胞生长因子/分散因子的表达
Am J Pathol. 1994 Apr;144(4):675-82.
9
Expression of scatter factor and c-met receptor in benign and malignant breast tissue.分散因子和c-met受体在乳腺良恶性组织中的表达。
Cancer. 1997 Feb 15;79(4):749-60. doi: 10.1002/(sici)1097-0142(19970215)79:4<749::aid-cncr12>3.0.co;2-#.
10
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis.肝细胞生长因子和Met受体在人胰腺癌发生中的表达
Am J Pathol. 1995 Oct;147(4):889-95.

引用本文的文献

1
Targeting c-MET Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications.靶向癌症中的c-MET改变:遗传驱动因素与治疗意义综述
Cancers (Basel). 2025 Apr 29;17(9):1493. doi: 10.3390/cancers17091493.
2
Opportunities and challenges of targeting c-Met in the treatment of digestive tumors.靶向c-Met在消化系统肿瘤治疗中的机遇与挑战
Front Oncol. 2022 Aug 1;12:923260. doi: 10.3389/fonc.2022.923260. eCollection 2022.
3
Therapeutic Targeting of Stromal-Tumor HGF-MET Signaling in an Organotypic Triple-Negative Breast Tumor Model.

本文引用的文献

1
Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells.肝细胞生长因子/分散因子是人类正常支气管上皮细胞和肺癌细胞的自分泌因子。
Cell Growth Differ. 1993 Jul;4(7):571-9.
2
Expression of the met/hepatocyte growth factor/scatter factor receptor and its ligand during differentiation of murine P19 embryonal carcinoma cells.间质表皮转化因子/肝细胞生长因子/分散因子受体及其配体在小鼠P19胚胎癌细胞分化过程中的表达
Dev Biol. 1993 Jun;157(2):308-20. doi: 10.1006/dbio.1993.1137.
3
Effect of hepatocyte growth factor on cadherin-mediated cell-cell adhesion.
在器官型三阴性乳腺癌模型中靶向基质-肿瘤 HGF-MET 信号传导的治疗。
Mol Cancer Res. 2022 Jul 6;20(7):1166-1177. doi: 10.1158/1541-7786.MCR-21-0317.
4
The Emerging Role of c-Met in Carcinogenesis and Clinical Implications as a Possible Therapeutic Target.c-Met在致癌作用中的新作用及其作为潜在治疗靶点的临床意义
J Oncol. 2022 Jan 13;2022:5179182. doi: 10.1155/2022/5179182. eCollection 2022.
5
Co-dependency for MET and FGFR1 in basal triple-negative breast cancers.基底三阴性乳腺癌中MET和FGFR1的共同依赖性
NPJ Breast Cancer. 2021 Mar 26;7(1):36. doi: 10.1038/s41523-021-00238-4.
6
Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A.针对三阴性乳腺癌中的 c-Met:使用 c-Met 抑制剂 Cpd A 的临床前研究。
Invest New Drugs. 2020 Oct;38(5):1365-1372. doi: 10.1007/s10637-020-00937-y. Epub 2020 Apr 22.
7
Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase.MET 的蛋白水解切割:受体酪氨酸激酶的分而治之策略。
BMB Rep. 2019 Apr;52(4):239-249. doi: 10.5483/BMBRep.2019.52.4.024.
8
MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk.MET/HGF 双重靶向治疗胰腺癌:深入了解肿瘤/基质相互作用的工具。
Int J Mol Sci. 2018 Dec 7;19(12):3920. doi: 10.3390/ijms19123920.
9
Cooperative Effect of Oncogenic and in an HGF-Dominant Environment in Breast Cancer.致癌基因和在 HGF 占主导地位的环境中在乳腺癌中的协同作用。
Mol Cancer Ther. 2019 Feb;18(2):399-412. doi: 10.1158/1535-7163.MCT-18-0710. Epub 2018 Dec 5.
10
Contribution of Adipose Tissue to Development of Cancer.脂肪组织对癌症发展的贡献。
Compr Physiol. 2017 Dec 12;8(1):237-282. doi: 10.1002/cphy.c170008.
肝细胞生长因子对钙黏蛋白介导的细胞间黏附的影响。
Cell Struct Funct. 1993 Apr;18(2):117-24. doi: 10.1247/csf.18.117.
4
Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.纤溶酶原激活剂、其抑制剂以及尿激酶受体在黑素细胞肿瘤进展的晚期出现。
Am J Pathol. 1994 Jan;144(1):70-81.
5
Molecular aspects of mesenchymal-epithelial interactions.间充质-上皮相互作用的分子层面
Annu Rev Cell Biol. 1993;9:511-40. doi: 10.1146/annurev.cb.09.110193.002455.
6
Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product.肝细胞生长因子/分散因子及其受体,即c-met原癌基因产物。
Biochim Biophys Acta. 1993 Dec 23;1155(3):357-71. doi: 10.1016/0304-419x(93)90015-5.
7
HGF-induced tubulogenesis and branching of epithelial cells is modulated by extracellular matrix and TGF-beta.肝细胞生长因子诱导的上皮细胞管状形成和分支受到细胞外基质和转化生长因子-β的调节。
Dev Biol. 1993 Dec;160(2):293-302. doi: 10.1006/dbio.1993.1308.
8
Microvascular pericytes express platelet-derived growth factor-beta receptors in human healing wounds and colorectal adenocarcinoma.微血管周细胞在人类愈合伤口和结肠直肠癌中表达血小板衍生生长因子-β受体。
Am J Pathol. 1993 Nov;143(5):1377-88.
9
Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor.分散因子调节EMT6小鼠乳腺肿瘤的转移表型。
Int J Cancer. 1994 Jun 1;57(5):706-14. doi: 10.1002/ijc.2910570517.
10
Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF.
J Biol Chem. 1994 Apr 29;269(17):12846-51.